173 related articles for article (PubMed ID: 7655175)
1. Bone loss in patients with inflammatory bowel disease: a prospective study.
Roux C; Abitbol V; Chaussade S; Kolta S; Guillemant S; Dougados M; Amor B; Couturier D
Osteoporos Int; 1995 May; 5(3):156-60. PubMed ID: 7655175
[TBL] [Abstract][Full Text] [Related]
2. Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study.
Schulte C; Dignass AU; Mann K; Goebell H
Scand J Gastroenterol; 1999 Jul; 34(7):696-702. PubMed ID: 10466881
[TBL] [Abstract][Full Text] [Related]
3. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.
Bastos CM; Araújo IM; Nogueira-Barbosa MH; Salmon CEG; de Paula FJA; Troncon LEA
Osteoporos Int; 2017 Jul; 28(7):2167-2176. PubMed ID: 28405731
[TBL] [Abstract][Full Text] [Related]
4. Bone density improves with disease remission in patients with inflammatory bowel disease.
Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
Jahnsen J; Falch JA; Aadland E; Mowinckel P
Gut; 1997 Mar; 40(3):313-9. PubMed ID: 9135518
[TBL] [Abstract][Full Text] [Related]
6. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
Koutroubakis IE; Zavos C; Damilakis J; Papadakis G; Neratzoulakis J; Karkavitsas N; Kouroumalis EA
J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
[TBL] [Abstract][Full Text] [Related]
7. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease.
Lamb EJ; Wong T; Smith DJ; Simpson DE; Coakley AJ; Moniz C; Muller AF
Aliment Pharmacol Ther; 2002 Nov; 16(11):1895-902. PubMed ID: 12390098
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseases.
Szymczak-Tomczak A; Krela-Kaźmierczak I; Kaczmarek-Ryś M; Hryhorowicz S; Stawczyk-Eder K; Szalata M; Skrzypczak-Zielińska M; Łykowska-Szuber L; Eder P; Michalak M; Dobrowolska A; Słomski R
Adv Clin Exp Med; 2019 Jul; 28(7):955-960. PubMed ID: 30929318
[TBL] [Abstract][Full Text] [Related]
9. [Bone mineral density in inflammatory bowel diseases in children].
Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
[TBL] [Abstract][Full Text] [Related]
12. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.
Schoon EJ; van Nunen AB; Wouters RS; Stockbrügger RW; Russel MG
Scand J Gastroenterol Suppl; 2000; (232):43-7. PubMed ID: 11232491
[TBL] [Abstract][Full Text] [Related]
13. How activity of inflammatory bowel disease influences bone loss.
Orlic ZC; Turk T; Sincic BM; Stimac D; Cvijanovic O; Maric I; Tomas MI; Jurisic-Erzen D; Licul V; Bobinac D
J Clin Densitom; 2010; 13(1):36-42. PubMed ID: 20171567
[TBL] [Abstract][Full Text] [Related]
14. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease.
Silvennoinen JA; Lehtola JK; Niemelä SE
Scand J Gastroenterol; 1996 Apr; 31(4):367-71. PubMed ID: 8726305
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections.
Staun M; Tjellesen L; Thale M; Schaadt O; Jarnum S
Scand J Gastroenterol; 1997 Mar; 32(3):226-32. PubMed ID: 9085459
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis and determinants of bone density in patients with Crohn's disease.
Robinson RJ; al-Azzawi F; Iqbal SJ; Kryswcki T; Almond L; Abrams K; Mayberry JF
Dig Dis Sci; 1998 Nov; 43(11):2500-6. PubMed ID: 9824142
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in Iranian patients with inflammatory bowel disease.
Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
[TBL] [Abstract][Full Text] [Related]
18. Metabolic bone assessment in patients with inflammatory bowel disease.
Abitbol V; Roux C; Chaussade S; Guillemant S; Kolta S; Dougados M; Couturier D; Amor B
Gastroenterology; 1995 Feb; 108(2):417-22. PubMed ID: 7835582
[TBL] [Abstract][Full Text] [Related]
19. [Bone mineral density evaluation in inflammatory bowel disease patients].
Lora FL; Amarante HM; Pisani JC; Borba VV; Kulak CA; Carmes ER
Arq Gastroenterol; 2005; 42(4):201-5. PubMed ID: 16444373
[TBL] [Abstract][Full Text] [Related]
20. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
